COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study
Gagandeep Brar(City of Hope), Manish A. Shah(NewYork–Presbyterian Hospital), Michael Shusterman(Cornell University), Peter Martin(Northwestern University), Evgeniya Reshetnyak(Cornell University), John L. Vaughn(Duke University), Laura C. Pinheiro(Cornell University), Doru Paul(Cornell University), Manuel Hidalgo(Hospital Universitario de Fuenlabrada), Samuel Yamshon(Cornell University), Orysya Soroka(Cornell University), Frank Chen(Douglas Mental Health University Institute), Brandon Swed(Cornell University)
Cited by 135
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k